1. Smolarz B, Nowak AZ, Romanowicz H. Breast Cancer-Epidemiology, Classification, Pathogenesis and Treatment (Review of Literature). Cancers (Basel). 2022;14(10):2569. doi:10.3390/cancers14102569 [
DOI:10.3390/cancers14102569] [
PMID] [
]
2. Azamjah N, Soltan-Zadeh Y, Zayeri F. Global Trend of Breast Cancer Mortality Rate: A 25-Year Study. Asian Pac J Cancer Prev. 2019;20(7):2015-20. doi:10.31557/APJCP.2019.20.7.2015 [
DOI:10.31557/APJCP.2019.20.7.2015] [
PMID] [
]
3. Caswell-Jin JL, Sun LP, Munoz D, Lu Y, Li Y, Huang H, et al. Analysis of Breast Cancer Mortality in the US-1975 to 2019. J JAMA. 2024 Jan 16;331(3):233-241. doi: 10.1001/jama.2023.25881. [
DOI:10.1001/jama.2023.25881] [
PMID] [
]
4. Ellington TD, Henley SJ, Wilson RJ, Miller JW, Wu M, Richardson LC. Trends in breast cancer mortality by race/ethnicity, age, and US census region, United States- 1999‐2020. Cancer. 2023;129(1):32-8. doi:10.1002/cncr.34503 [
DOI:10.1002/cncr.34503] [
PMID] [
]
5. Suter MB, Pesapane F, Agazzi GM, Gagliardi T, Nigro O, Bozzini A, et al. Diagnostic accuracy of contrast-enhanced spectral mammography for breast lesions: A systematic review and meta-analysis. Breast. 2020;53:8-17. doi:10.1016/j.breast.2020.06.005 [
DOI:10.1016/j.breast.2020.06.005] [
PMID] [
]
6. Mahdavifar N, Pakzad R, Ghoncheh M, Pakzad I, Moudi A, Salehiniya H. Spatial Analysis of Breast Cancer Incidence in Iran. Asian Pac J Cancer Prev. 2016;17(S3):59-64. doi:10.7314/apjcp.2016.17.s3.59 [
DOI:10.7314/APJCP.2016.17.S3.59] [
PMID]
7. Nafissi N, Khayamzadeh M, Zeinali Z, Pazooki D, Hosseini M, Akbari ME. Epidemiology and Histopathology of Breast Cancer in Iran versus Other Middle Eastern Countries. Middle East Journal of Cancer. 2018;9:243-51. doi:10.30476/mejc.2018.42130
8. Rahimzadeh S, Burczynska B, Ahmadvand A, Sheidaei A, Khademioureh S, Pazhuheian F, et al. Geographical and socioeconomic inequalities in female breast cancer incidence and mortality in Iran: A Bayesian spatial analysis of registry data. PLoS One. 2021;16(3):e0248723. doi:10.1371/journal.pone.0248723 [
DOI:10.1371/journal.pone.0248723] [
PMID] [
]
9. Obeagu EI, Obeagu GU. Breast cancer: A review of risk factors and diagnosis. Medicine (Baltimore). 2024;103(3):e36905. doi:10.1097/MD.0000000000036905 [
DOI:10.1097/MD.0000000000036905] [
PMID] [
]
10. Cuthrell KM, Tzenios N. Breast Cancer: Updated and Deep Insights. International Research Journal of Oncology. 2023;6(1): 104-18.
11. Fuentes JDB, Morgan E, de Luna Aguilar A, Mafra A, Shah R, Giusti F, et al. Global stage distribution of breast cancer at diagnosis: a systematic review and meta-analysis. JAMA oncology. 2024. doi:10.1001/jamaoncol.2023.4837 [
DOI:10.1001/jamaoncol.2023.4837] [
PMID] [
]
12. Steinhof-Radwanska K, Lorek A, Holecki M, Barczyk-Gutkowska A, Grazynska A, Szczudlo-Chrascina J, et al. Multifocality and Multicentrality in Breast Cancer: Comparison of the Efficiency of Mammography, Contrast-Enhanced Spectral Mammography, and Magnetic Resonance Imaging in a Group of Patients with Primarily Operable Breast Cancer. Curr Oncol. 2021;28(5):4016-30. doi:10.3390/curroncol28050341 [
DOI:10.3390/curroncol28050341] [
PMID] [
]
13. Tse T, Sehdev S, Seely J, Gravel DH, Clemons M, Cordeiro E, et al. Neoadjuvant chemotherapy in breast cancer: review of the evidence and conditions that facilitated its use during the global pandemic. Current Oncology. 2021;28(2):1338-47. [
DOI:10.3390/curroncol28020127] [
PMID] [
]
14. Boros M, Voidazan S, Moldovan C, Georgescu R, Toganel C, Moncea D, et al. Clinical implications of multifocality as a prognostic factor in breast carcinoma-a multivariate analysis study comprising 460 cases. International Journal of Clinical and Experimental Medicine. 2015;8(6):9839.
15. Milulescu A, Di Marino L, Peradze N, Toesca A. Management of Multifocal-Multicentric Breast Cancer: Current Perspective. Chirurgia (Bucur). 2017;112(1):12-7. doi:10.21614/chirurgia.112.1.12 [
DOI:10.21614/chirurgia.112.1.12] [
PMID]
16. Guadalupe LDP, De Jesús J, Xiong Y, Rosa M. Tumor size and focality in breast carcinoma: analysis of concordance between radiological imaging modalities and pathological examination at a cancer center. Annals of Diagnostic Pathology. 2020;48:151601. [
DOI:10.1016/j.anndiagpath.2020.151601] [
PMID]
17. Watkins EJ. Overview of breast cancer. JAAPA. 2019;32(10):13-7. doi:10.1097/01.JAA.0000580524.95733.3d [
DOI:10.1097/01.JAA.0000580524.95733.3d] [
PMID]
18. Grabinski VF, Brawley OW. Disparities in Breast Cancer. Obstet Gynecol Clin North Am. 2022;49(1):149-65. doi:10.1016/j.ogc.2021.11.010 [
DOI:10.1016/j.ogc.2021.11.010] [
PMID]
19. Autier P, Boniol M. Mammography screening: A major issue in medicine. Eur J Cancer. 2018;90:34-62. doi:10.1016/j.ejca.2017.11.002 [
DOI:10.1016/j.ejca.2017.11.002] [
PMID]
20. Houssami N, Turner R, Morrow M. Preoperative magnetic resonance imaging in breast cancer: meta-analysis of surgical outcomes. Ann Surg. 2013;257(2):249-55. doi:10.1097/SLA.0b013e31827a8d17 [
DOI:10.1097/SLA.0b013e31827a8d17] [
PMID]
21. Iamurri AP, Ponziani M, Macchini M, Fogante M, Pistelli M, De Lisa M, et al. Evaluation of multifocality and multicentricity with breast magnetic resonance imaging in each breast cancer subtype. Clinical Breast Cancer. 2018;18(2):e231-e5. [
DOI:10.1016/j.clbc.2017.10.012] [
PMID]
22. Wecsler J, Jeong YJ, Raghavendra AS, Mack WJ, Tripathy D, Yamashita MW, et al. Factors associated with MRI detection of occult lesions in newly diagnosed breast cancers. J Surg Oncol. 2020;121(4):589-98. doi:10.1002/jso.25855 [
DOI:10.1002/jso.25855] [
PMID] [
]
23. Ataseven B, Lederer B, Blohmer JU, Denkert C, Gerber B, Heil J, et al. Impact of multifocal or multicentric disease on surgery and locoregional, distant and overall survival of 6,134 breast cancer patients treated with neoadjuvant chemotherapy. Annals of surgical oncology. 2015;22(4):1118-27. doi:10.1245/s10434-014-4122-7. [
DOI:10.1245/s10434-014-4122-7] [
PMID]
24. Bae MS, Chang JM, Cho N, Han W, Ryu HS, Moon WK. Association of preoperative breast MRI features with locoregional recurrence after breast conservation therapy. Acta Radiol. 2018;59(4):409-17. doi:10.1177/0284185117723041 [
DOI:10.1177/0284185117723041] [
PMID]
25. Houssami N, Turner RM, Morrow M. Meta-analysis of pre-operative magnetic resonance imaging (MRI) and surgical treatment for breast cancer. Breast Cancer Res Treat. 2017;165(2):273-83. doi:10.1007/s10549-017-4324-3 [
DOI:10.1007/s10549-017-4324-3] [
PMID] [
]
26. Chirita A. Indications of the Magnetic Resonance Method in Breast Pathology. Chirurgia (Bucur). 2017;112(4):367-77. doi:10.21614/chirurgia.112.4.367 [
DOI:10.21614/chirurgia.112.4.367] [
PMID]